UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000027659
Receipt number R000031677
Scientific Title The efficacy of obturator nerve block in pain management of total knee arthroplasty
Date of disclosure of the study information 2017/06/06
Last modified on 2018/09/14 17:06:57

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The efficacy of obturator nerve block in pain management of total knee arthroplasty

Acronym

The efficacy of obturator nerve block in pain management of total knee arthroplasty

Scientific Title

The efficacy of obturator nerve block in pain management of total knee arthroplasty

Scientific Title:Acronym

The efficacy of obturator nerve block in pain management of total knee arthroplasty

Region

Japan


Condition

Condition

gonarthrosis

Classification by specialty

Anesthesiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To confirm the efficacy of analgesia of an obturator nerve block added to the femoral block in total knee arthroplasty

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

analgesia of tourniquet pain and postoperative pain

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

We performed one type of peripheral nerve block,femoral nerve block (0.25% levobupivacaine 20ml, containing dexamethasone 3.3mg) alone before the surgery of total knee arthroplasty. And we provided a continuous femoral nerve block catheter (0.1% levobupivacaine 4 ml/h) for postoperative analgesia.

Interventions/Control_2

We performed two types of peripheral nerve block, femoral nerve block (0.25% levobupivacaine 20 ml, containing dexamethasone 3.3mg) and obturator nerve block (0.25% levobupivacaine 20 ml, containing dexamethasone 3.3mg) before the surgery of total knee arthroplasty.And we provided a continuous femoral nerve block catheter (0.1% levobupivacaine 4 ml/h) for postoperative analgesia.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

85 years-old >

Gender

Male and Female

Key inclusion criteria

patients who underwent total knee arthroplasty in general anesthesia and agreed with peripheral nerve block

Key exclusion criteria

ASA physical status>3
BMI>35
allergy to local anesthetic
contraindications to regional anesthesia
preexisting neurological deficits in the lower extremities
inability to comprehend pain scales

Target sample size

40


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Kataoka Asako

Organization

Otsu City Hospital

Division name

Anesthesiology

Zip code


Address

Motomiya2-9-9,Otsu,Shiga

TEL

077-522-4607

Email

asakomatsuda724@gmail.com


Public contact

Name of contact person

1st name
Middle name
Last name Kataoka Asako

Organization

Otsu City Hospital

Division name

Anesthesiology

Zip code


Address

Motomiya2-9-9,Otsu,Shiga

TEL

077-522-4607

Homepage URL


Email

asakomatsuda724@gmail.com


Sponsor or person

Institute

Otsu City Hospital

Institute

Department

Personal name



Funding Source

Organization

nothing

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2017 Year 06 Month 06 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Terminated

Date of protocol fixation

2017 Year 06 Month 01 Day

Date of IRB


Anticipated trial start date

2017 Year 06 Month 06 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2017 Year 06 Month 06 Day

Last modified on

2018 Year 09 Month 14 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000031677


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name